中文

Hong Kong Stocks · Free Data Page

SKB BIO 06990

SKB BIO: FY2025 revenue CN¥2.06B (+6.50% YoY); net income -CN¥382.0M; 3 alerts, 0 watch items out of 17 risk checks; no TTM dividend.
Close PriceHK$442.40Day +10.16%Market CapHK$105.7BP/E577.8xTTMP/B17.21xROE (FY2025)-9.3%Avg. equity

Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for SKB BIO?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2021–2025

Financial statements are reported in CNY, while share price and market cap are quoted in HKD.

Key Multi-Year Facts

  • Revenue moved from CN¥32.3M in FY2021 to CN¥2.06B in FY2025 (4-year CAGR +182.5%).
  • Net income was negative in FY2021, FY2022, FY2023, FY2024, FY2025.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (CNY B)0.030.801.541.932.06
YoY—2387.3%91.6%25.5%6.5%
Net Income (CNY B)-0.89-0.62-0.57-0.27-0.38
Operating Cash Flow (CNY B)-0.49-0.270.06-0.43-0.18
ROE——-24.6%-9.5%-9.3%
Gross Margin36.5%65.6%49.3%65.9%71.9%
Net Margin-2752.9%-76.6%-37.3%-13.8%-18.6%
Debt-to-Assets425.2%424.8%33.6%22.5%18.7%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-05

Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).

3Alert 0Watch 12Pass 2N/A

Items Flagged for Review

  • Alert

    Inventory DaysFinancial Quality

    151.9 days, prior FY 61.2 days(+148%)

    FY2025 (ended 2025-12-31) · What is this?

  • Alert

    Interest CoverageSolvency

    Negative (negative EBIT)

    FY2025 (ended 2025-12-31) · What is this?

  • Alert

    Net LossesGoing Concern

    FY2025 (2025-12-31) CN¥-0.38B, FY2024 (2024-12-31) CN¥-0.27B

    FY2025 (ended 2025-12-31)

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

Dividends

No dividends paid over the trailing 12 months.

Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.

More data: All research reports · Sector leaders · Market hours & holidays.

Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.